Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

L'Oreal Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (17)
Cancellation by sponsor (14)

Date

2025 (6)
2024 (2)
2023 (5)
2022 (1)
2020 (2)
2019 (1)
2018 (5)
2017 (1)
2014 (8)

Search

Sponsor content

31 result(s) found, displaying 11 to 20

La Roche-Posay Laboratoire Determologique Dermo Pediatrics- Spray SPF50+ Infant Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by L'Oreal Australia Pty Ltd
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS XL ULTRA LIGHT TINTED FLUID SPF50+ Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by L'Oreal Australia Pty Ltd
La Roche-Posay Laboratoire Dermatologique Anthelios XL Fluid Ultra Light SPF50+ Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by L'Oreal Australia Pty Ltd
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE UVIDEA XL DAILY PROTECTION MELT IN CREAM SPF50 Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by L'Oreal Australia Pty Ltd
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS SPF 50+ VERY HIGH PROTECTION INVISIBLE FLUID (315643)

22 March 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS SPF 50+ VERY HIGH PROTECTION INVISIBLE FLUID.
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS XL DRY TOUCH GEL-CREAM SPF50+ (308621)

24 August 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS XL DRY TOUCH GEL-CREAM SPF50+.
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS XL DRY TOUCH TINTED GEL-CREAM SPF50+ (308618)

24 August 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS XL DRY TOUCH TINTED GEL-CREAM SPF50+.
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+ (307005)

13 July 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+.
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA COMFORT NON PERFUMED CREAM SPF50+ (307004)

13 July 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA COMFORT NON PERFUMED CREAM SPF50+.
ANTHELIOS wet skin sunscreen SPF50+ (300899)

16 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ANTHELIOS wet skin sunscreen SPF50+.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.